Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells.

Opavsky R, Wang SH, Trikha P, Raval A, Huang Y, Wu YZ, Rodriguez B, Keller B, Liyanarachchi S, Wei G, Davuluri RV, Weinstein M, Felsher D, Ostrowski M, Leone G, Plass C.

PLoS Genet. 2007 Sep;3(9):1757-69. Epub 2007 Aug 16.

2.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

3.

Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.

van Doorn R, Zoutman WH, Dijkman R, de Menezes RX, Commandeur S, Mulder AA, van der Velden PA, Vermeer MH, Willemze R, Yan PS, Huang TH, Tensen CP.

J Clin Oncol. 2005 Jun 10;23(17):3886-96. Epub 2005 May 16.

PMID:
15897551
4.

A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.

Yu L, Liu C, Bennett K, Wu YZ, Dai Z, Vandeusen J, Opavsky R, Raval A, Trikha P, Rodriguez B, Becknell B, Mao C, Lee S, Davuluri RV, Leone G, Van den Veyver IB, Caligiuri MA, Plass C.

Genomics. 2004 Oct;84(4):647-60.

PMID:
15475242
5.

Predicting aberrant CpG island methylation.

Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12253-8. Epub 2003 Sep 30.

6.
7.
8.

CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.

Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M.

Oncogene. 2010 Dec 2;29(48):6390-401. doi: 10.1038/onc.2010.361. Epub 2010 Aug 30.

9.

Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.

Liu WB, Han F, Du XH, Jiang X, Li YH, Liu Y, Chen HQ, Ao L, Cui ZH, Cao J, Liu JY.

Int J Cancer. 2014 Mar 15;134(6):1311-22. doi: 10.1002/ijc.28472. Epub 2013 Nov 11.

10.

Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.

Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ.

Clin Cancer Res. 2002 Apr;8(4):1087-92.

11.

Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas.

Peters SL, Hlady RA, Opavska J, Klinkebiel D, Novakova S, Smith LM, Lewis RE, Karpf AR, Simpson MA, Wu L, Opavsky R.

Mol Cell Biol. 2013 Nov;33(21):4321-33. doi: 10.1128/MCB.00776-13. Epub 2013 Sep 3.

12.

CpG content affects gene silencing in mice: evidence from novel transgenes.

Chevalier-Mariette C, Henry I, Montfort L, Capgras S, Forlani S, Muschler J, Nicolas JF.

Genome Biol. 2003;4(9):R53. Epub 2003 Aug 14.

13.

Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.

Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS.

Mod Pathol. 2006 Aug;19(8):1083-90. Epub 2006 May 12.

14.

Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.

Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lübbert M, Zhou JH, Benedict WF, Jones PA.

J Natl Cancer Inst. 2001 Oct 3;93(19):1465-72.

PMID:
11584062
15.

Alterations of DNA methylation in hematologic malignancies.

Rush LJ, Plass C.

Cancer Lett. 2002 Nov 8;185(1):1-12. Review.

PMID:
12142073
16.

Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.

Agrelo R, Setien F, Espada J, Artiga MJ, Rodriguez M, Pérez-Rosado A, Sanchez-Aguilera A, Fraga MF, Piris MA, Esteller M.

J Clin Oncol. 2005 Jun 10;23(17):3940-7. Epub 2005 May 2.

PMID:
15867203
17.

Prediction of epigenetically regulated genes in breast cancer cell lines.

Loss LA, Sadanandam A, Durinck S, Nautiyal S, Flaucher D, Carlton VE, Moorhead M, Lu Y, Gray JW, Faham M, Spellman P, Parvin B.

BMC Bioinformatics. 2010 Jun 4;11:305. doi: 10.1186/1471-2105-11-305.

18.

Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.

Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG.

Cancer Res. 2001 Dec 15;61(24):8611-6.

19.

An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.

Holm K, Staaf J, Lauss M, Aine M, Lindgren D, Bendahl PO, Vallon-Christersson J, Barkardottir RB, Höglund M, Borg Å, Jönsson G, Ringnér M.

Breast Cancer Res. 2016 Feb 29;18(1):27. doi: 10.1186/s13058-016-0685-5.

20.

Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.

Alaminos M, Davalos V, Cheung NK, Gerald WL, Esteller M.

J Natl Cancer Inst. 2004 Aug 18;96(16):1208-19.

PMID:
15316056

Supplemental Content

Support Center